FDA · Drug recall
Minocycline Hydrochloride Capsules USP…
- Date
- April 13, 2016
- Risk class
- Class III (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences)
- Status
- Terminated
- Filed by
- Apace KY LLC
- Product
- Minocycline Hydrochloride Capsules USP, 100 mg*, 30 Capsules (3 x 10) Unit Dose blisters (NDC 50268-569-11, barcode 5026856911) per carton (NDC 50268-569-13, barcode 5026856913), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478.
- Reason
- Labeling: Incorrect or Missing Lot and/or Exp Date: the individual blisters are mislabeled with an incorrect lot number of 13560 rather than the correct lot number of 13650.
- Distribution pattern
- All product was shipped to KY and further distributed Nationwide
- Quantity
- 291 cartons
- Codes and lots
- Outer Cases and Cartons Lot #: 13650, EXP 06/2017; Blisters Lot #: 13560, EXP 06/2017
- Recall started
- Feb. 12, 2016
- Recall number
- D-0811-2016
What should I do? Medicine recall: what to do
Source: FDA · Drug enforcement report, recall number D-0811-2016. The agency record governs; check it and the company before acting.